TY - JOUR
KW - opioid use disorder
KW - opioid agonist treatment
KW - Methadone
KW - buprenorphine
KW - buprenorphine naloxone
KW - Treatment engagement
KW - Empirical Study
KW - Followup Study
KW - Longitudinal Study
KW - Retrospective Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Young Adulthood (18-29 yrs)
KW - Thirties (30-39 yrs)
KW - naloxone
KW - Substance use treatment
KW - article
KW - Canada
KW - 3383:Drug & Alcohol Rehabilitation
AU - Emanuel Krebs
AU - Fahmida Homayra
AU - Jeong E. Min
AU - Sue MacDonald
AU - Leila Gold
AU - Connie Carter
AU - Bohdan Nosyk
A1 - 
AD - BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada bnosyk@sfu.ca; Vancouver Coastal Health, Vancouver, BC, Canada ; British Columbia Ministry of Mental Health and Addictions, Victoria, BC, Canada ; Nosyk, Bohdan,8888 University Drive,Burnaby,Canada,V5A 1S6,Faculty of Health Sciences, Simon Fraser University,bnosyk@sfu.ca
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
DO - 10.1016/j.drugalcdep.2021.108799
JF - Drug and alcohol dependence
LA - English
M1 - Journal Article
PY - 2021
SN - 0376-8716, 0376-8716
SP - 5
T1 - Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012–2018
T2 - Drug and alcohol dependence
TI - Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012–2018
U1 - Opioids & Substance Use
U3 - 10.1016/j.drugalcdep.2021.108799
UR - https://www.proquest.com/scholarly-journals/characterizing-opioid-agonist-treatment/docview/2559463865/se-2?accountid=28100
VL - 225
VO - 0376-8716, 0376-8716
Y1 - 2021
Y2 - Aug 01
ER -